NIVABUPA Niva Bupa Health Insurance Company Q4 FY26 results (Jan–Mar 2026) and concall
Niva Bupa Health reported strong financial results for Q4 and full year FY26, driven by robust GWP growth, significant PAT increase, and improved operational efficiency. The company saw its combined ratio improve and expense ratio decline, while also gaining retail health market share. Management highlighted strategic investments in distribution, technology, and healthcare initiatives to sustain growth and profitability.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 34.7%, net profit down 22.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,321 | 1,258 | 1,671 | 1,932 | 1,574 +19% | 1,611 +28% | 2,251 +35% |
| EBITDA | -66 | -24 | 251 | 98 | -53 +20% | -94 −292% | 182 −27% |
| Net profit | 13 | 13 | 206 | 71 | -35 −369% | -88 −777% | 159 −23% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
